Analyst
Bernstein
Equibles does not estimate personal net worth.
Lee Hambright is recorded as Analyst at Bernstein. Lee Hambright has spoken on 2 investor events across 2 companies, most recently for Johnson & Johnson on May 27, 2026. Those appearances were for Johnson & Johnson (JNJ) and Boston Scientific Corp (BSX). The companies whose calls Lee Hambright spoke on are classified in the Healthcare sector.
“We are delighted to host Johnson & Johnson, Chairman and CEO, Joaquin Duato. Thank you so much for being here. We are scheduled for a 50-minute fireside chat here.”
“We're very pleased to kick off the Strategic Decision Conference again with Boston Scientific. We've got Mike Mahoney, Chairman and CEO, and Ken Stein, Chief Medical Officer.”
Bernstein
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
